Clinical trial
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
NCT05848713 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
- Lead sponsor
- University of Manitoba
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- October 10, 2023
- Completion date
- March 31, 2029
- Enrollment
- 4,000 (estimated)
- Sites
- 68
Conditions
As the registry lists them; a condition with its own page is linked.